Published in J Virol on March 01, 2005
Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell (2010) 4.33
IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A (2007) 3.98
Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell Host Microbe (2009) 3.79
Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J Virol (2006) 3.60
Influenza virus assembly and budding. Virology (2011) 2.90
Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J Virol (2007) 2.82
Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology (2007) 2.68
Cellular networks involved in the influenza virus life cycle. Cell Host Microbe (2010) 2.23
Distinct domains of the influenza a virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production. J Virol (2006) 2.18
The influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding. J Virol (2008) 2.12
Mutational analysis of cis-acting RNA signals in segment 7 of influenza A virus. J Virol (2008) 2.10
The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly. J Virol (2006) 2.07
Influenza virus morphogenesis and budding. Virus Res (2009) 2.07
Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments. Expert Rev Vaccines (2009) 1.83
Simulation and prediction of the adaptive immune response to influenza A virus infection. J Virol (2009) 1.76
Influenza virus m2 ion channel protein is necessary for filamentous virion formation. J Virol (2010) 1.73
Three-dimensional analysis of ribonucleoprotein complexes in influenza A virus. Nat Commun (2012) 1.64
Viroporins: structure and biological functions. Nat Rev Microbiol (2012) 1.56
Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain. PLoS Pathog (2012) 1.55
At the centre: influenza A virus ribonucleoproteins. Nat Rev Microbiol (2014) 1.33
RAB11A is essential for transport of the influenza virus genome to the plasma membrane. J Virol (2011) 1.29
The lack of an inherent membrane targeting signal is responsible for the failure of the matrix (M1) protein of influenza A virus to bud into virus-like particles. J Virol (2010) 1.25
Colocalization of different influenza viral RNA segments in the cytoplasm before viral budding as shown by single-molecule sensitivity FISH analysis. PLoS Pathog (2013) 1.23
Novel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants. J Virol (2007) 1.20
Elevated 17β-estradiol protects females from influenza A virus pathogenesis by suppressing inflammatory responses. PLoS Pathog (2011) 1.18
Evolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis. Virol J (2009) 1.18
Influenza A virus lacking M2 protein as a live attenuated vaccine. J Virol (2009) 1.16
The RNA binding domain of influenza A virus NS1 protein affects secretion of tumor necrosis factor alpha, interleukin-6, and interferon in primary murine tracheal epithelial cells. J Virol (2007) 1.13
The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles. J Virol (2006) 1.09
Novel vaccines against influenza viruses. Virus Res (2011) 1.04
Severe acute respiratory syndrome coronavirus gene 7 products contribute to virus-induced apoptosis. J Virol (2007) 1.02
Bovine ephemeral fever rhabdovirus α1 protein has viroporin-like properties and binds importin β1 and importin 7. J Virol (2013) 1.02
Palmitoylation of the influenza A virus M2 protein is not required for virus replication in vitro but contributes to virus virulence. J Virol (2009) 1.00
Tyrosines in the influenza A virus M2 protein cytoplasmic tail are critical for production of infectious virus particles. J Virol (2010) 0.99
Bidirectional virus secretion and nonciliated cell tropism following Andes virus infection of primary airway epithelial cell cultures. J Virol (2006) 0.98
Studies of an influenza A virus temperature-sensitive mutant identify a late role for NP in the formation of infectious virions. J Virol (2008) 0.97
Native morphology of influenza virions. Front Microbiol (2012) 0.95
Biological activities of 'noninfectious' influenza A virus particles. Future Virol (2014) 0.95
Cytoplasmic domain of influenza B virus BM2 protein plays critical roles in production of infectious virus. J Virol (2007) 0.94
A comprehensive map of the influenza A virus replication cycle. BMC Syst Biol (2013) 0.93
Virus-like particles as universal influenza vaccines. Expert Rev Vaccines (2012) 0.93
M2e-Based Universal Influenza A Vaccines. Vaccines (Basel) (2015) 0.93
The cholesterol recognition/interaction amino acid consensus motif of the influenza A virus M2 protein is not required for virus replication but contributes to virulence. Virology (2010) 0.91
Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 protein. Virol J (2009) 0.90
Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine. Vaccine (2011) 0.88
Human annexin A6 interacts with influenza a virus protein M2 and negatively modulates infection. J Virol (2011) 0.88
Influenza virus pathogenicity is determined by caspase cleavage motifs located in the viral proteins. J Mol Genet Med (2009) 0.87
Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype. Vaccine (2010) 0.87
Extending the cytoplasmic tail of the influenza a virus M2 protein leads to reduced virus replication in vivo but not in vitro. J Virol (2007) 0.87
Mutations in the membrane-proximal region of the influenza A virus M2 protein cytoplasmic tail have modest effects on virus replication. J Virol (2011) 0.85
A Coronavirus E Protein Is Present in Two Distinct Pools with Different Effects on Assembly and the Secretory Pathway. J Virol (2015) 0.85
Caveolin-1 influences human influenza A virus (H1N1) multiplication in cell culture. Virol J (2010) 0.82
Role of the CM2 protein in the influenza C virus replication cycle. J Virol (2010) 0.81
Chemical ligation of the influenza M2 protein for solid-state NMR characterization of the cytoplasmic domain. Protein Sci (2015) 0.79
An M2 cytoplasmic tail mutant as a live attenuated influenza vaccine against pandemic (H1N1) 2009 influenza virus. Vaccine (2011) 0.78
The nucleoprotein and matrix protein segments of H5N1 influenza viruses are responsible for dominance in embryonated eggs. J Gen Virol (2011) 0.78
The Feat of Packaging Eight Unique Genome Segments. Viruses (2016) 0.77
Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells. Vaccine (2017) 0.77
Restricted replication of the live attenuated influenza A virus vaccine during infection of primary differentiated human nasal epithelial cells. Vaccine (2015) 0.76
Detection of proton movement directly across viral membranes to identify novel influenza virus M2 inhibitors. J Virol (2013) 0.76
Epitope Mapping of Avian Influenza M2e Protein: Different Species Recognise Various Epitopes. PLoS One (2016) 0.75
Lateral Organization of Influenza Virus Proteins in the Budozone Region of the Plasma Membrane. J Virol (2017) 0.75
Progesterone-Based Contraceptives Reduce Adaptive Immune Responses and Protection against Sequential Influenza A Virus Infections. J Virol (2017) 0.75
Influenza A Virus Hemagglutinin is Required for the Assembly of Viral Components Including Bundled vRNPs at the Lipid Raft. Viruses (2016) 0.75
M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice. Vaccine (2016) 0.75
Estrogenic compounds reduce influenza A virus replication in primary human nasal epithelial cells derived from female, but not male, donors. Am J Physiol Lung Cell Mol Physiol (2015) 0.75
Host cellular protein TRAPPC6AΔ interacts with influenza A virus M2 protein and regulates viral propagation by modulating M2 trafficking. J Virol (2016) 0.75
NB protein does not affect influenza B virus replication in vitro and is not required for replication in or transmission between ferrets. J Gen Virol (2015) 0.75
The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells. Vaccine (2017) 0.75
Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene (1991) 38.64
Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A (1999) 14.90
Amplification, expression, and packaging of foreign gene by influenza virus. Cell (1989) 11.21
Influenza virus M2 protein has ion channel activity. Cell (1992) 8.52
The molecular basis of the specific anti-influenza action of amantadine. EMBO J (1985) 7.08
Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell (1985) 6.44
Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc Natl Acad Sci U S A (1981) 5.57
Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol (1988) 5.31
Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell (1991) 4.97
Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J Virol (1993) 4.76
Determination of influenza virus proteins required for genome replication. J Virol (1990) 4.36
Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement. J Clin Virol (2004) 4.28
Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology (1991) 3.83
Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci U S A (2003) 3.45
Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. EMBO J (1997) 3.23
The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers. Virology (1992) 3.19
Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukaemia cells. J Physiol (1996) 3.03
Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture. J Virol (2002) 2.97
Transport of incoming influenza virus nucleocapsids into the nucleus. J Virol (1991) 2.92
Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc Natl Acad Sci U S A (2003) 2.83
Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes. J Virol (2003) 2.67
An influenza virus containing nine different RNA segments. Virology (1991) 2.66
Characterization of the influenza virus M2 integral membrane protein and expression at the infected-cell surface from cloned cDNA. J Virol (1985) 2.58
On the mechanism of inhibition of influenza virus replication by amantadine hydrochloride. J Gen Virol (1978) 2.50
Influenza virus matrix protein is the major driving force in virus budding. J Virol (2000) 2.49
The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Virology (1998) 2.43
Expression of influenza A virus internal antigens on the surface of infected P815 cells. J Immunol (1981) 2.36
Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport. J Virol (1994) 2.31
Evidence that the amantadine-induced, M2-mediated conversion of influenza A virus hemagglutinin to the low pH conformation occurs in an acidic trans Golgi compartment. Virology (1992) 2.25
Plasmid-driven formation of influenza virus-like particles. J Virol (2000) 2.18
Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein. J Virol (1994) 2.17
Mechanism for proton conduction of the M(2) ion channel of influenza A virus. J Biol Chem (2000) 2.13
Influence of amantadine resistance mutations on the pH regulatory function of the M2 protein of influenza A viruses. Virology (1992) 2.13
Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. J Virol (2001) 2.04
Permeation and activation of the M2 ion channel of influenza A virus. J Biol Chem (2000) 1.90
Efficient formation of influenza virus-like particles: dependence on the expression levels of viral proteins. J Gen Virol (1999) 1.89
Effect of cytoplasmic tail truncations on the activity of the M(2) ion channel of influenza A virus. J Virol (1999) 1.87
The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus. J Cell Biol (1996) 1.83
Influenza B virus BM2 protein has ion channel activity that conducts protons across membranes. Dev Cell (2003) 1.77
Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein. Proc Natl Acad Sci U S A (1989) 1.69
Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity. J Virol (2001) 1.63
Regulation of pH by the M2 protein of influenza A viruses. Virus Res (1992) 1.63
The crystal structure of the influenza matrix protein M1 at neutral pH: M1-M1 protein interfaces can rotate in the oligomeric structures of M1. Virology (2001) 1.63
The cytoplasmic tails of the influenza virus spike glycoproteins are required for normal genome packaging. Virology (2000) 1.61
A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria. J Gen Virol (2004) 1.57
Evidence for segment-nonspecific packaging of the influenza a virus genome. J Virol (2002) 1.51
Isolation of matrix protein M1 from influenza viruses by acid-dependent extraction with nonionic detergent. Virology (1992) 1.47
Role of transmembrane domain and cytoplasmic tail amino acid sequences of influenza a virus neuraminidase in raft association and virus budding. J Virol (2004) 1.46
Integration of a small integral membrane protein, M2, of influenza virus into the endoplasmic reticulum: analysis of the internal signal-anchor domain of a protein with an ectoplasmic NH2 terminus. J Cell Biol (1988) 1.44
Influenza virus uncoating in infected cells and effect of rimantadine. J Gen Virol (1982) 1.43
Solubilization of matrix protein M1/M from virions occurs at different pH for orthomyxo- and paramyxoviruses. Virology (1990) 1.42
Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly. Virology (1995) 1.35
Influenza B virus BM2 protein is an oligomeric integral membrane protein expressed at the cell surface. Virology (2003) 1.34
Combined results from solution studies on intact influenza virus M1 protein and from a new crystal form of its N-terminal domain show that M1 is an elongated monomer. Virology (2001) 1.29
The utility of siRNA transcripts produced by RNA polymerase i in down regulating viral gene expression and replication of negative- and positive-strand RNA viruses. Virology (2003) 1.25
Influenza B virus BM2 protein is a crucial component for incorporation of viral ribonucleoprotein complex into virions during virus assembly. J Virol (2004) 1.19
Chimeric influenza A viruses with a functional influenza B virus neuraminidase or hemagglutinin. J Virol (2003) 1.12
Nucleotide sequences of influenza A virus RNA segment 7: a comparison of five isolates. Nucleic Acids Res (1989) 1.09
Influenza B virus requires BM2 protein for replication. J Virol (2004) 1.08
The CM2 protein of influenza C virus is an oligomeric integral membrane glycoprotein structurally analogous to influenza A virus M2 and influenza B virus NB proteins. Virology (1997) 1.06
Influenza C virus CM2 integral membrane glycoprotein is produced from a polypeptide precursor by cleavage of an internal signal sequence. Proc Natl Acad Sci U S A (1998) 1.03
Uncoating of a rimantadine-resistant variant of influenza virus in the presence of rimantadine. J Gen Virol (1982) 1.02
Influenza virus M2 protein slows traffic along the secretory pathway. pH perturbation of acidified compartments affects early Golgi transport steps. J Biol Chem (1998) 1.02
Influenza B virus BM2 protein is transported through the trans-Golgi network as an integral membrane protein. J Virol (2003) 0.89
Reduced incorporation of the influenza B virus BM2 protein in virus particles decreases infectivity. Virology (2004) 0.88
Detection of ion channel activity in Xenopus laevis oocytes expressing Influenza C virus CM2 protein. Arch Virol (2003) 0.87
Identification of a membrane targeting and degradation signal in the p42 protein of influenza C virus. J Virol (2000) 0.81
IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A (2007) 3.98
Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J Virol (2006) 3.60
Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture. J Virol (2002) 2.97
The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis (2010) 2.54
Distinct domains of the influenza a virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production. J Virol (2006) 2.18
Bioluminescence imaging of vaccinia virus: effects of interferon on viral replication and spread. Virology (2005) 1.89
Virus-inducible reporter genes as a tool for detecting and quantifying influenza A virus replication. J Virol Methods (2005) 1.62
Dendritic cells respond to influenza virus through TLR7- and PKR-independent pathways. Eur J Immunol (2005) 1.62
Interferon-producing cells fail to induce proliferation of naive T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells. J Exp Med (2003) 1.54
No evidence of infection with avian influenza viruses among US poultry workers in the Delmarva Peninsula, Maryland and Virginia, USA. J Agromedicine (2011) 1.47
Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses. Proc Natl Acad Sci U S A (2010) 1.42
Influenza virus-like particles containing M2 induce broadly cross protective immunity. PLoS One (2011) 1.40
The utility of siRNA transcripts produced by RNA polymerase i in down regulating viral gene expression and replication of negative- and positive-strand RNA viruses. Virology (2003) 1.25
Structure and intracellular targeting of the SARS-coronavirus Orf7a accessory protein. Structure (2005) 1.16
The RNA binding domain of influenza A virus NS1 protein affects secretion of tumor necrosis factor alpha, interleukin-6, and interferon in primary murine tracheal epithelial cells. J Virol (2007) 1.13
Mind the gap: social media engagement by public health researchers. J Med Internet Res (2014) 1.12
Tropism and infectivity of influenza virus, including highly pathogenic avian H5N1 virus, in ferret tracheal differentiated primary epithelial cell cultures. J Virol (2012) 1.10
The impact of sex, gender and pregnancy on 2009 H1N1 disease. Biol Sex Differ (2010) 1.10
The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles. J Virol (2006) 1.09
Differentiated cultures of primary hamster tracheal airway epithelial cells. In Vitro Cell Dev Biol Anim (2005) 1.08
Roles for the recycling endosome, Rab8, and Rab11 in hantavirus release from epithelial cells. Virology (2008) 1.06
Severe acute respiratory syndrome coronavirus gene 7 products contribute to virus-induced apoptosis. J Virol (2007) 1.02
Palmitoylation of the influenza A virus M2 protein is not required for virus replication in vitro but contributes to virus virulence. J Virol (2009) 1.00
Tyrosines in the influenza A virus M2 protein cytoplasmic tail are critical for production of infectious virus particles. J Virol (2010) 0.99
Bidirectional virus secretion and nonciliated cell tropism following Andes virus infection of primary airway epithelial cell cultures. J Virol (2006) 0.98
The cholesterol recognition/interaction amino acid consensus motif of the influenza A virus M2 protein is not required for virus replication but contributes to virulence. Virology (2010) 0.91
Antibody responses and cross protection against lethal influenza A viruses differ between the sexes in C57BL/6 mice. Vaccine (2011) 0.90
Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype. Vaccine (2010) 0.87
Influenza A virus infection of primary differentiated airway epithelial cell cultures derived from Syrian golden hamsters. Virology (2006) 0.87
Extending the cytoplasmic tail of the influenza a virus M2 protein leads to reduced virus replication in vivo but not in vitro. J Virol (2007) 0.87
Prospects for oral replicating adenovirus-vectored vaccines. Vaccine (2013) 0.86
Mutations in the membrane-proximal region of the influenza A virus M2 protein cytoplasmic tail have modest effects on virus replication. J Virol (2011) 0.85
An immunosuppressed Syrian golden hamster model for SARS-CoV infection. Virology (2008) 0.84
The transmembrane domain of the severe acute respiratory syndrome coronavirus ORF7b protein is necessary and sufficient for its retention in the Golgi complex. J Virol (2008) 0.82
Influenza virus assays based on virus-inducible reporter cell lines. Influenza Other Respir Viruses (2009) 0.81
Production and characterization of monoclonal antibodies against the nucleocapsid protein of SARS-CoV. Adv Exp Med Biol (2006) 0.79
Seoul virus suppresses NF-kappaB-mediated inflammatory responses of antigen presenting cells from Norway rats. Virology (2010) 0.78
Transcriptional profiling of the spleen in progressive visceral leishmaniasis reveals mixed expression of type 1 and type 2 cytokine-responsive genes. BMC Immunol (2014) 0.77